![Development of SGC-GAK-1 as an orally active in vivo probe for cyclin G associated kinase through cytochrome P450 inhibition | bioRxiv Development of SGC-GAK-1 as an orally active in vivo probe for cyclin G associated kinase through cytochrome P450 inhibition | bioRxiv](https://www.biorxiv.org/content/biorxiv/early/2019/05/07/629220/F1.large.jpg)
Development of SGC-GAK-1 as an orally active in vivo probe for cyclin G associated kinase through cytochrome P450 inhibition | bioRxiv
![BAY-474, a SGC Epigenetic Probe, is a Tyrosine-Protein Kinase c-Met Inhibitor - Network of Cancer Research BAY-474, a SGC Epigenetic Probe, is a Tyrosine-Protein Kinase c-Met Inhibitor - Network of Cancer Research](https://www.cancer-research-network.com/wp-content/uploads/BAY-474-a-SGC-Epigenetic-Probe-is-a-Tyrosine-Protein-Kinase-c-Met-Inhibitor-2020-02-02.jpg)
BAY-474, a SGC Epigenetic Probe, is a Tyrosine-Protein Kinase c-Met Inhibitor - Network of Cancer Research
SGC epigenetic probe distribution by year of approval and target class... | Download Scientific Diagram
![Testing of the SGC epigenetic library of chemical probes on five BTICs... | Download Scientific Diagram Testing of the SGC epigenetic library of chemical probes on five BTICs... | Download Scientific Diagram](https://www.researchgate.net/publication/305806216/figure/fig1/AS:391293088878610@1470302950958/Testing-of-the-SGC-epigenetic-library-of-chemical-probes-on-five-BTICs-lines-A-Detailed.png)
Testing of the SGC epigenetic library of chemical probes on five BTICs... | Download Scientific Diagram
![Target 2035 – an update on private sector contributions - RSC Medicinal Chemistry (RSC Publishing) DOI:10.1039/D2MD00441K Target 2035 – an update on private sector contributions - RSC Medicinal Chemistry (RSC Publishing) DOI:10.1039/D2MD00441K](https://pubs.rsc.org/image/article/2023/MD/d2md00441k/d2md00441k-f2_hi-res.gif)